retatrutide phase 2 trial obesity nejm 2023 (not yet approved in US but people using anyway) promises even potentially greater weight loss amongst the GLP1 drugs. https://www.nejm .org/doi/full/10.1056/NEJMoa2301972 Retatrutide Phase 2 NEJM Trial:

Much less clear at this time is whether that benefit would accrue to those for whom these drugs are not currently indicated

Preparing for your Phoenix peptide therapy journey Maximize your results by preparing appropriately before beginning peptide therapy

doi: 10.1152/ajpgi.1998.275.5.G984 81 LeePJPapachristouGI

While Semaglutide GLP-1 can help lose weight effectively for patients within this criteria, you should still follow your physicians recommendations

Sugary drinks, creamy coffees and calorie-heavy smoothies can quickly take up a disproportionate share of daily intake without providing lasting satisfaction